tracheal intubation. Unspecified adverse effect of drug or medicament
Conditions
Interventions
Intervention 1: (group A) use of intravenous hypnotic anesthetic (propofol) with dosage of 150ug/kg/min have received in during general anesthesia. Intervention 2: (group B) use of volatile anestheti
Early detection
(group A) use of intravenous hypnotic anesthetic (propofol) with dosage of 150ug/kg/min have received in during general anesthesia
(group B) use of volatile anesthetic (isofluranl) 1% in during general anesthesia
(group C) use of Patients in the intravenous hypnotic anesthetic (propofol) with dosage of 150ug/kg/min with N2o ratio 50-50 in general anesthesia
(group D) use of volatile anesthtic(isofluran) 1% with N2O ratio 50-50in general anesthesia
Sponsors
Vice Chancellor of Research of Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: Patients undergoing elective surgery; ASA class I and II exclusion criteria: Patients outside the age range 15 to 65 years; patients with a high ASA class II; patients with systemic disease heart- lung, renal endocrine or metabolic; morbid obesity (BMI>40); Surgical practice time for less than 1.5 hour; positions other than supine; head and neck and thoracic surgery; neck rotation during surgery more than 10 degrees; Endotracheal tube cuff pressure increases to more than 40 cmH2o during anesthesia; difficult intubation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tracheal cuff pressure. Timepoint: Before the experiment and then every 30 minutes. Method of measurement: In millimeters of mercury using a cuff pressure manometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: end of study. Method of measurement: Manometer to measure the pressure.;Heart rate. Timepoint: end of study. Method of measurement: with pulse oxymetry. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed